Nov 15, 2026
The U.S. Supreme Court on Thursday maintained access to the abortion pill mifepristone through telehealth and mail delivery, setting aside lower court restrictions while litigation over the drug continues. Mifepristone is used in more than 60% of U.S. abortions.